YishengBio Co.

[WEB-INTEL 2026-08-26] 7 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "YS Biopharma at pre-money equity value of $834 million" [https://www.prnewswire.com/news-releases/ys-biopharma-to-merge-with-nasdaq-listed-summit-healthcare-acquisition-corp-301637273.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Certain investors ("Forward Purchase Investors") are expected to invest $30 million in a private placement concurrently with the closing of the business combination transaction pursuant to certain forward purchase agreements" [https://www.prnewswire.com/news-releases/ys-biopharma-to-merge-with-nasdaq-listed-summit-healthcare-acquisition-corp-301637273.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Up to 2,732,325 incentive bonus shares, including up to 1,285,800 shares to be newly issued by the combined entity and 1,446,525 shares to be contributed by the sponsor of Summit Healthcare Acquisition Corp., will be provided to non-redeemi" [https://www.prnewswire.com/news-releases/ys-biopharma-to-merge-with-nasdaq-listed-summit-healthcare-acquisition-corp-301637273.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The business combination transaction is targeted to close in the first quarter of 2023" [https://www.prnewswire.com/news-releases/ys-biopharma-to-merge-with-nasdaq-listed-summit-healthcare-acquisition-corp-301637273.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held on March 1, 2023 at 9:00 a.m. Eastern Time" [https://www.prnewswire.com/news-releases/summit-healthcare-acquisition-corp-and-ys-biopharma-announce-effectiveness-of-registration-statement-and-extraordinary-general-meeting-date-for-proposed-business-combination-301741339.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The Business Combination is expected to officially close on March 16, 2023." [https://www.nasdaq.com/press-release/ys-biopharma-and-summit-healthcare-announce-shareholder-approval-of-business] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Summit Healthcare and YS Biopharma completed the business combination on March 16, 2023." [https://www.cooley.com/news/coverage/2023/2023-03-20-summit-healthcare-closes-business-combination-with-ys-biopharma]